Suxia Lin

1.8k total citations
57 papers, 1.2k citations indexed

About

Suxia Lin is a scholar working on Oncology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Suxia Lin has authored 57 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 23 papers in Pathology and Forensic Medicine and 12 papers in Immunology. Recurrent topics in Suxia Lin's work include Lymphoma Diagnosis and Treatment (20 papers), Viral-associated cancers and disorders (12 papers) and Lung Cancer Treatments and Mutations (5 papers). Suxia Lin is often cited by papers focused on Lymphoma Diagnosis and Treatment (20 papers), Viral-associated cancers and disorders (12 papers) and Lung Cancer Treatments and Mutations (5 papers). Suxia Lin collaborates with scholars based in China, United States and Hong Kong. Suxia Lin's co-authors include M. Zheng, Jim Ropchan, Richard E. Carson, Stefani Corsi-Travali, Marc N. Potenza, Dennis W. Raisch, Ching‐Yuan Kuo, Andrew M. Evens, Borko Jovanovic and Soheila Najafzadeh and has published in prestigious journals such as JAMA, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Suxia Lin

55 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suxia Lin China 14 364 349 306 208 172 57 1.2k
Michele Stanislaw Milella Italy 18 537 1.5× 195 0.6× 529 1.7× 33 0.2× 82 0.5× 92 1.2k
Soo Hyun Yang South Korea 16 495 1.4× 83 0.2× 397 1.3× 21 0.1× 81 0.5× 41 1.3k
Johannes Klose Germany 17 75 0.2× 271 0.8× 61 0.2× 43 0.2× 114 0.7× 54 987
Thomas Rothämel Germany 13 101 0.3× 101 0.3× 49 0.2× 127 0.6× 126 0.7× 35 798
Victoria Croog United States 10 270 0.7× 246 0.7× 55 0.2× 18 0.1× 73 0.4× 27 888
Joo Hyun Kim South Korea 31 216 0.6× 395 1.1× 54 0.2× 21 0.1× 817 4.8× 91 2.1k
Michel Fausther United States 21 190 0.5× 137 0.4× 181 0.6× 19 0.1× 83 0.5× 37 1.1k
Makoto Terada Japan 17 78 0.2× 121 0.3× 82 0.3× 33 0.2× 31 0.2× 35 989
D. Geißler Austria 20 66 0.2× 205 0.6× 37 0.1× 48 0.2× 74 0.4× 67 1.4k
Daniele Mauro Italy 22 135 0.4× 94 0.3× 42 0.1× 30 0.1× 93 0.5× 62 1.6k

Countries citing papers authored by Suxia Lin

Since Specialization
Citations

This map shows the geographic impact of Suxia Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suxia Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suxia Lin more than expected).

Fields of papers citing papers by Suxia Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suxia Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suxia Lin. The network helps show where Suxia Lin may publish in the future.

Co-authorship network of co-authors of Suxia Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Suxia Lin. A scholar is included among the top collaborators of Suxia Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suxia Lin. Suxia Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Xuanye, Mengyao Zhou, Lina Hu, et al.. (2024). Angioimmunoblastic T-cell lymphoma involving the nasopharynx: An easily misdiagnosed disease with atypical histopathological features. Human Pathology. 145. 86–94. 1 indexed citations
3.
4.
Li, Bob T., Jietian Jin, Valerie W. Rusch, et al.. (2021). Modification of Pathologic T Classification for Non-small Cell Lung Cancer With Visceral Pleural Invasion. CHEST Journal. 160(2). 754–764. 14 indexed citations
5.
Luo, Min, Fang Wang, Hong Zhang, et al.. (2021). PD0325901, an ERK inhibitor, enhances the efficacy of PD-1 inhibitor in non-small cell lung carcinoma. Acta Pharmaceutica Sinica B. 11(10). 3120–3133. 24 indexed citations
7.
Hu, Wanming, Jietian Jin, Chenyan Wu, et al.. (2019). Expression of P63 and its correlation with prognosis in diffuse large B-cell lymphoma: a single center experience. Diagnostic Pathology. 14(1). 128–128. 6 indexed citations
8.
Lin, Suxia, Bin He, Sijin Wu, et al.. (2018). Recurrent ECSIT mutation encoding V140A triggers hyperinflammation and promotes hemophagocytic syndrome in extranodal NK/T cell lymphoma. Nature Medicine. 24(2). 154–164. 49 indexed citations
9.
Lin, Jianwen, et al.. (2015). Association between angiotensinogen T174M polymorphism and ischemic stroke: A meta-analysis. Journal of Research in Medical Sciences. 20(6). 619–619. 3 indexed citations
11.
Sun, Xiaofei, Zijun Zhen, Suxia Lin, et al.. (2014). Treatment Outcome of Chinese Children with Anaplastic Large Cell Lymphoma by Using a Modified B-NHL-BFM-90 Protocol. Pediatric Hematology and Oncology. 31(6). 518–527. 4 indexed citations
12.
Normandin, Marc D., Robert H. Pietrzak, Daniele Piomelli, et al.. (2013). Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study. Molecular Psychiatry. 18(9). 1034–1040. 261 indexed citations
13.
Lin, Guimiao, Qiang Chen, Suxia Lin, et al.. (2013). Overexpression of human telomerase reverse transcriptase C-terminal polypeptide sensitizes HeLa cells to 5-fluorouracil-induced growth inhibition and apoptosis. Molecular Medicine Reports. 9(1). 279–284. 8 indexed citations
14.
Lin, Guimiao, Marie C.M. Lin, Suxia Lin, et al.. (2012). Early Growth Response Protein-1 Promoter-Mediated Synergistic Antitumor Effect of hTERTC27 Gene Therapy and 5-Flurorouracil on Nasopharyngeal Carcinoma. Cancer Biotherapy and Radiopharmaceuticals. 27(7). 434–441. 2 indexed citations
15.
Xu, Gaixia, Suxia Lin, Wing‐Cheung Law, et al.. (2012). The Invasion and Reproductive Toxicity of QDs-Transferrin Bioconjugates on Preantral Follicle in vitro. Theranostics. 2(7). 734–745. 25 indexed citations
16.
Evens, Andrew M., Borko Jovanovic, Yu‐Chieh Su, et al.. (2010). Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports. Annals of Oncology. 22(5). 1170–1180. 256 indexed citations
17.
Yang, Jing, et al.. (2010). Clinicopathologic features of primary lymphoma in soft tissue. Leukemia & lymphoma. 51(11). 2039–2046. 11 indexed citations
18.
Yin, Weihua, Hui‐Lan Rao, Suxia Lin, et al.. (2010). [Follicular dendritic cell sarcoma: a clinicopathologic analysis of ten cases].. PubMed. 39(8). 522–7. 4 indexed citations
19.
Chang, Chawnshang, et al.. (1999). Allogeneic bone marrow transplantation of chronic myeloid leukemia from an HLA-matched unrelated donor with the beta-thalassemic trait.. PubMed. 69(3). 200–2.
20.
Lin, Suxia, et al.. (1991). Remission of hypoplastic acute leukemia by low dose Ara-C: one case report.. PubMed. 7(10). 531–5.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026